Robot-assisted Versus Open Lateral Pancreaticojejunostomy for the Treatment of Symptomatic Chronic Pancreatitis (PANACOTTA)

Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Study ID
NCT07109180
Status
Recruiting
Apply to this trial

Conditions

  • Chronic Pancreatitis
  • Minimally Invasive Surgery
  • Minimally Invasive Surgical Technique
  • Pancreaticojunostomy
  • Robot Surgery
  • Robot Surgica
  • Surgery

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Robot-assisted lateral pancreaticojejunostomy — PROCEDURE
    Robot-assisted
  • Open lateral pancreaticojejunostomy — PROCEDURE
    Open surgery

Study Details

PANACOTTA is a multicenter randomized controlled trial including patients with symptomatic chronic pancreatitis and a dilated main pancreatic duct to either robot-assisted or open lateral pancreaticojejunostomy. The PANACOTTA trial will assess the post-operative quality of recovery following robot-assisted versus open lateral pancreaticojejunostomy.

Key Dates

First listed
Aug 7, 2025
Start date
Apr 16, 2025
Status verified
Jul 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
28 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Robot-assisted lateral pancreaticojejunostomy
  • Active Comparator: Open lateral pancreaticojejunostomy

Primary Outcome Measure

Quality of Recovery (QoR-15) [ Time Frame: Daily assessments on Post-operative Day 1 through Day 5 and up to time of functional recovery, defined individually per patient (maximum of 90 days from surgery). ]

Central Contacts

Related Studies